Skip to content

Kevin R Sayer, Executive Chair at Dexcom, sold DXCM on Aug 20, 2026

Data as of Oct 16

▼ SELL$667K7,351 shares at $90.78Kevin R Sayer Executive ChairDXCM Dexcom Inc
Watch DXCM
Traded
Aug 20, 2026
Disclosed
Aug 24, 2026
Filed
4 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Kevin R Sayer, Executive Chair at Dexcom, sold DXCM on Aug 20, 2026TRADEDDISCLOSED
DXCMSimilar stocks (XLV — its sector index fund), rebased to DXCM's price on the disclosure day
DXCM since disclosure
−5.5%
after the sale
Similar stocks (XLV) since disclosure
+1.2%
XLV — its sector index fund

Change in closing price from Aug 24, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLKevin R Sayer Executive ChairDXCM Dexcom Inc$1.7Mdisclosed Aug 24 · filed 4 days after the trade
  2. ▼ SELLKevin R Sayer Executive ChairDXCM Dexcom Inc$8.9Kdisclosed Aug 24 · filed 4 days after the trade

See every trade on DXCM →